Evidence map›Paper›PMID 37945916›Full record

ArticleScientific reports2023

Establishment and validation of a nomogram model for riskprediction of hepatic encephalopathy: a retrospective analysis.

Chun Yao, Liangjiang Huang, Meng Wang, Dewen Mao, Minggang Wang, Jinghui Zheng, Fuli Long, Jingjing Huang, Xirong Liu, Rongzhen Zhang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Chun YaoGuangxi University of Chinese Medicine, Nanning, 530001, Guangxi, People's Republic of China.
Liangjiang HuangGuangxi University of Chinese Medicine, Nanning, 530001, Guangxi, People's Republic of China.
Meng WangFirst Affiliated Hospital of Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530001, Guangxi, People's Republic of China.
Dewen MaoFirst Affiliated Hospital of Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530001, Guangxi, People's Republic of China.
Minggang WangFirst Affiliated Hospital of Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530001, Guangxi, People's Republic of China.
Jinghui ZhengGuangxi University of Chinese Medicine, Nanning, 530001, Guangxi, People's Republic of China.
Fuli LongFirst Affiliated Hospital of Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530001, Guangxi, People's Republic of China.
Jingjing HuangFirst Affiliated Hospital of Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530001, Guangxi, People's Republic of China.
Xirong LiuFirst Affiliated Hospital of Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530001, Guangxi, People's Republic of China.
Rongzhen ZhangFirst Affiliated Hospital of Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530001, Guangxi, People's Republic of China.
Jiacheng XieGuangxi University of Chinese Medicine, Nanning, 530001, Guangxi, People's Republic of China.
Chen ChengFirst Affiliated Hospital of Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530001, Guangxi, People's Republic of China.
Fan YaoFirst Affiliated Hospital of Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530001, Guangxi, People's Republic of China.
Guochu HuangFirst Affiliated Hospital of Guangxi University of Chinese Medicine, 89-9 Dongge Road, Nanning, 530001, Guangxi, People's Republic of China. 349661907@qq.com.
Guangxi University of Chinese Medicine · CNThe First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To establish a high-quality, easy-to-use, and effective risk prediction model for hepatic encephalopathy, to help healthcare professionals with identifying people who are at high risk of getting hepatic encephalopathy, and to guide them to take early interventions to reduce the occurrence of hepatic encephalopathy. Patients (n = 1178) with decompensated cirrhosis who attended the First Affiliated Hospital of Guangxi University of Chinese Medicine between January 2016 and June 2022 were selected for the establishment and validation of a nomogram model for risk prediction of hepatic encephalopathy. In this study, we screened the risk factors for the development of hepatic encephalopathy in patients with decompensated cirrhosis by univariate analysis, LASSO regression and multifactor analysis, then established a nomogram model for predicting the risk of getting hepatic encephalopathy for patients with decompensated cirrhosis, and finally performed differentiation analysis, calibration analysis, clinical decision curve analysis and validation of the established model. A total of 1178 patients with decompensated cirrhosis who were hospitalized and treated at the First Affiliated Hospital of Guangxi University of Chinese Medicine between January 2016 and June 2022 were included for modeling and validation. Based on the results of univariate analysis, LASSO regression analysis and multifactor analysis, a final nomogram model with age, diabetes, ascites, spontaneous peritonitis, alanine transaminase, and blood potassium as predictors of hepatic encephalopathy risk prediction was created. The results of model differentiation analysis showed that the AUC of the model of the training set was 0.738 (95% CI 0.63-0.746), while the AUC of the model of the validation set was 0.667 (95% CI 0.541-0.706), and the two AUCs indicated a good discrimination of this nomogram model. According to the Cut-Off value determined by the Jorden index, when the Cut-Off value of the training set was set at 0.150, the sensitivity of the model was 72.8%, the specificity was 64.8%, the positive predictive value was 30.4%, and the negative predictive value was 91.9%; when the Cut-Off value of the validation set was set at 0.141, the sensitivity of the model was 69.7%, the specificity was 57.3%, the positive predictive value was 34.5%, and the negative predictive value was 84.7%. The calibration curve and the actual events curve largely overlap at the diagonal, indicating that the prediction with this model has less error. The Hosmer-Lemeshow test for goodness of fit was also applied, and the results showed that for the training set, χ

Indexed as

Hepatic EncephalopathyPeritonitisAgedAscitesChinaHumansNomogramsPotassiumRetrospective StudiesPotassium

Identifiers

PMID37945916
PMCPMC10636098
OpenAlexW4388520398

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.